Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lafutidine (FRG-8813) is a newly developed histamine H(2)-receptor antagonist, which can inhibit gastric acid secretion.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 9,500 | |||
50 mg | 在庫あり | ¥ 15,500 | |||
100 mg | 在庫あり | ¥ 22,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Lafutidine (FRG-8813) is a newly developed histamine H(2)-receptor antagonist, which can inhibit gastric acid secretion. |
別名 | FRG-8813 |
分子量 | 431.55 |
分子式 | C22H29N3O4S |
CAS No. | 118288-08-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 80 mg/mL (185.4 mM)
Ethanol: 11 mg/mL (25.5 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lafutidine 118288-08-7 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor 5-HT Receptor inhibit gastric mucus antiulcer reflux mucosal antisecretory Inhibitor histamine protective disease secretion FRG 8813 colonic FRG8813 receptor gastroesophageal FRG-8813 inhibitor